French perfume maker and distributor that develops and markets fragrances under licensed fashion and lifestyle brand names.
French perfume maker and distributor that develops and markets fragrances under licensed fashion and lifestyle brand names.
Holds licences to make and sell fragrances for fashion and luxury brands, paying the brand owners royalties on sales, so growth depends on renewing licences and winning new ones. A few brands account for much of sales, and the founders, Philippe Benacin and Jean Madar, control it through a holding company.
In one line: A licensed-brand fragrance house like Coty's prestige arm.
Moat: narrow (brand, distribution). Long-term exclusive licenses with fashion brands and global distribution network, but license renewal risk.
Headquarters: Paris, France · Founded: 1982 · Employees: 378
Size Interparfums (ITP.PA) is a France Consumer Staples company (Household/Personal Care) with a market value of $3.49B, the 78th largest of 206 France companies the cockpit tracks. Shares closed at €36.16 on 18 Nov 2026.
Performance Over six months the shares gained 65.9%, against +0.3% for the median peer and -2.1% for the France market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue fell 4.2% over the last twelve months (peer median +4.3%); the operating margin is 18.3% (peer median 11.5%).
Valuation It trades at 26.9× forward earnings against a peer median of 18.8× (7th most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -4 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 5.4 points above its cost of capital (10.8% WACC).
Next results Next results expected around 24 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | €867M | €899M | €880M | €798M | €707M |
| Revenue growth | — | +2% | +10% | +13% | — |
| Gross profit | €551M | €565M | €561M | €516M | €458M |
| EBITDA | €179M | €202M | €195M | €182M | €156M |
| Net income | €119M | €127M | €130M | €119M | €99.5M |
| Free cash flow | €166M | €127M | €101M | €72.1M | €52.4M |
| Capital expenditure | €8.44M | €40.5M | €20.5M | €54.0M | €77.8M |
| Total debt | n/a | €152M | €147M | €138M | €160M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Interparfums ITP.PA | $3.49B | +66% | -4% | 18% | 26.9× | 15.6% |
| Coty COTY | $3.71B | +116% | 0% | 5% | 13.5× | 9.8% |
| Puig Brands PUIG.MC | $12.4B | +31% | +4% | 16% | 18.1× | -2.6% |
| L'Oreal OR.PA | $259B | +20% | +3% | 21% | 32.3× | 18.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ITP.PA | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +11.5% | +0.9% | 6th highest of 21 |
| 6-month return | +65.9% | +0.3% | 3rd highest of 21 |
| Distance from 52-week high | -2.8% | -22.4% | 2nd highest of 21 |
| Revenue growth (TTM) | -4.2% | +4.3% | 2nd lowest of 21 |
| Operating margin | 18.3% | 11.5% | 8th highest of 21 |
| Forward P/E | 26.9× | 18.8× | 7th most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 15.6% | 0.9% | 4th most demanding of 17 |
| Growth delivered (Del g) | +19.6% | +6.0% | 5th highest of 17 |
| Hurdle (Req g minus delivered) | -4.0 pp | -2.6 pp | 8th least demanding of 17 |
| ROIC minus cost of capital | +5.4 pp | +3.7 pp | 8th highest of 19 |
| EV / EBITDA | 17.8× | 10.5× | 5th most expensive of 17 |
| Net debt / EBITDA | 0.1× | -0.8× | 6th most indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Interparfums ITP.PA | France | $3.49B | +66% | -4% | 18% | 26.9× | 15.6% | +19.6% |
| Coty COTY | United States | $3.71B | +116% | 0% | 5% | 13.5× | 9.8% | +4.6% |
| Hengan Int'l 1044.HK | Hong Kong | $3.27B | -12% | +2% | 11% | 9.1× | -8.2% | -0.1% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.25B | +20% | +2% | 6% | 48.7× | 18.0% | +1.9% |
| Lion 4912.T | Japan | $3.85B | +44% | +6% | 8% | 24.3× | 0.9% | +3.5% |
| Rohto Pharmaceutical 4527.T | Japan | $3.87B | +8% | +7% | 12% | 16.5× | -2.8% | +13.7% |
| Proya Cosmetics 603605.SS | China | $2.87B | -13% | +2% | 13% | 10.9× | -5.3% | +23.1% |
| LG H&h 051900.KS | South Korea | $2.81B | -14% | -3% | 3% | 23.1× | -4.6% | -4.1% |
| Mao Geping Cosmetics 1318.HK | Hong Kong | $4.67B | -8% | +32% | 31% | 14.3× | 4.1% | +41.1% |
| Gillette India GILLETTE.NS | India | $2.53B | -5% | +8% | 28% | 37.1× | 14.9% | +13.0% |
| Winner Medical 300888.SZ | China | $2.53B | -6% | +4% | 11% | 19.9× | -5.2% | -2.6% |
| Cosmax 192820.KS | South Korea | $2.51B | +53% | +25% | 8% | 18.8× | n/a | n/a |
| Colgate-Palmolive (India) COLPAL.NS | India | $4.91B | -23% | +9% | 28% | 32.4× | 31.1% | +4.5% |
| Giant Biogene 2367.HK | Hong Kong | $2.47B | -32% | -10% | 32% | 8.6× | -10.7% | +34.9% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.37B | -30% | -2% | 24% | 27.0× | 21.2% | +7.4% |
| Cupid CUPID.NS | India | $5.22B | +218% | +125% | 33% | n/a | n/a | n/a |
| Reynolds Consumer Products REYN | United States | $5.28B | +15% | +2% | 14% | 15.3× | 0.8% | +2.7% |
| Softcare 2698.HK | Hong Kong | $2.20B | +5% | +25% | 25% | 14.4× | 9.1% | +20.9% |
| KOSE 4922.T | Japan | $2.16B | +16% | +4% | 5% | 29.9× | n/a | n/a |
| Blue Moon 6993.HK | Hong Kong | $2.07B | -4% | -2% | -2% | 103.3× | n/a | n/a |
| Kolmar Korea 161890.KS | South Korea | $2.05B | +14% | +16% | 10% | 14.3× | -1.6% | +15.5% |